Central retinal vein occlusion 36-month outcomes with anti-vascular endothelial growth factors: the Fight Retinal Blindness! registry Save Sight Registries Central retinal vein occlusion 36-month outcomes with anti-vascular endothelial growth factors: the Fight Retinal Blindness! registry Read More »
Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! Registry Save Sight Registries Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! Registry Read More »
Five-year corneal cross-linking outcomes: A Save Sight Keratoconus Registry Study Save Sight Registries Five-year corneal cross-linking outcomes: A Save Sight Keratoconus Registry Study Read More »
Oxygen in Corneal Collagen Crosslinking to Treat Keratoconus: A Systematic Review and Meta-Analysis Save Sight Registries Oxygen in Corneal Collagen Crosslinking to Treat Keratoconus: A Systematic Review and Meta-Analysis Read More »
Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry study Save Sight Registries Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry study Read More »
Patient-Reported Outcomes in Keratoconus: A Save Sight Keratoconus Registry Study Save Sight Registries Patient-Reported Outcomes in Keratoconus: A Save Sight Keratoconus Registry Study Read More »
Characterization of poor visual outcomes of diabetic macular edema: the Fight Retinal Blindness! Project Save Sight Registries Characterization of poor visual outcomes of diabetic macular edema: the Fight Retinal Blindness! Project Read More »
Three-year treatment outcomes of Aflibercept versus Ranibizumab for diabetic macular edema: data from the Fight Retinal Blindness! Registry Save Sight Registries Three-year treatment outcomes of Aflibercept versus Ranibizumab for diabetic macular edema: data from the Fight Retinal Blindness! Registry Read More »
Twelve-month treatment outcomes of macular edema following central retinal vein occlusion using aflibercept or ranibizumab in routine clinical practice – data from the Fight Retinal Blindness! project Save Sight Registries Twelve-month treatment outcomes of macular edema following central retinal vein occlusion using aflibercept or ranibizumab in routine clinical practice – data from the Fight Retinal Blindness! project Read More »
12-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry Save Sight Registries 12-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry Read More »
Efficacy and safety of standard corneal cross-linking procedures performed with short versus standard riboflavin induction: A Save Sight Keratoconus Registry Study Mia Rainey Efficacy and safety of standard corneal cross-linking procedures performed with short versus standard riboflavin induction: A Save Sight Keratoconus Registry Study Read More »
Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry Save Sight Registries Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry Read More »
